Par Drugs and Chemicals Limited — Others, 01-01-2025: Shareholders meeting

PAR Drugs and Chemicals held an Extra Ordinary General Meeting (EGM) where all resolutions proposed were rejected, failing to achieve the requisite majority. The resolutions included a slump sale of company assets and a venture into real estate and renewable energy businesses. A total of approximately 80% of shareholders voted, but the proposals faced significant opposition with around 63% voting against each resolution. This outcome may lead to strategic reevaluation, affecting potential growth areas and investor sentiment, likely resulting in a cautious outlook for shareholders concerned about the company's future direction and governance.